Cargando…

WCN23-0651 LONG-TERM EFFECTIVENESS OF COVID-19 VACCINE AMONG DIALYSIS PATIENTS

Detalles Bibliográficos
Autores principales:	Rosa Diez, G., Papaginovic Leiva, M.M., Lombi, F., Crucelegui, M.S., Luxardo, R., Giordani, M.C., Martinez, R.D., Trimarchi, H., Schiavelli, R., Grizzo, M., Raño, M., Heguilen, R.M., Gonzalez Paganti, L., Pagotto, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Covid-19 and CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025613/ http://dx.doi.org/10.1016/j.ekir.2023.02.1009

Ejemplares similares

WCN23-0655 INCIDENCE AND OUTCOMES OF COVID-19 IN DIALYSIS PATIENTS. DATA FROM THE ARGENTINE REGISTRY OF CHRONIC DIALYSIS
por: Bisigniano, L., et al.
Publicado: (2023)

WCN23-1086 ACUTE KIDNEY INJURY AFTER COVID 19 INFECTION IN CHRONIC KIDNEY DISEASE PATIENTS OF BANGLADESH: RETROSPECTIVE STUDY
por: NOBI, F., et al.
Publicado: (2023)

WCN23-0825 TELENEPHROLOGY: MANAGING CHRONIC KIDNEY DISEASE DURING COVID-19 PANDEMIC
por: Sharma, S.K., et al.
Publicado: (2023)

WCN23-0345 EFFECTIVENESS OF COVID-19 VACCINE IN PATIENT UNDERGOING HEMODIALYSIS
por: FATIMAH, S., et al.
Publicado: (2023)

WCN23-0981 RISK FACTORS FOR COVID-19 MORTALITY IN HEMODIALYSIS PATIENTS
por: TOMANOSKI, V., et al.
Publicado: (2023)

WCN23-0787 A CASE OF IGA VASCULITIS THAT DEVELOPED GROSS HEMATURIA AND LOWER-LIMB PURPURA FOLLOWING COVID-19 VACCINES
por: MORI, K., et al.
Publicado: (2023)

WCN23-0616 SARS-COV-2 INFECTION AMONG HOSPITALIZED PATIENTS WITH CHRONIC KIDNEY DISEASE
por: Munaa, B., et al.
Publicado: (2023)

WCN23-0430 PREDICTORS FOR FAILURE REDUCTION OF HEMODIALYSIS FREQUENCY DURING THE PANDEMIC
por: Pattharanitima, P., et al.
Publicado: (2023)

WCN23-0938 IMPACT OF THE COVID-19 PANDEMIC IN PATIENTS ATTENDING RENAL CLINIC AT KINGSTON PUBLIC HOSPITAL, JAMAICA
por: DEWAR, D., et al.
Publicado: (2023)

WCN23-0389 ASSOCIATED FACTORS TO CLINICAL OUTCOMES OF COVID-19 AMONG HOSPITALIZED PATIENTS UNDERGOING MAINTENANCE DIALYSIS
por: MEDRIANO, R., et al.
Publicado: (2023)

WCN23-1183 DISPARITIES IN CHRONIC KIDNEY DISEASE RISKS: DATA FROM THE CURE-CKD COVID-19 REGISTRY
por: Nicholas, S., et al.
Publicado: (2023)

WCN23-0519 VACCINE RESPONSE AGAINST SARS-Cov-2 AMONG HEMODIALYSIS PATIENTS IN TWO SENEGALESE CENTERS IN 2021
por: MOTOULA LATOU, L.N.P., et al.
Publicado: (2023)

WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19
por: BRAZ, B., et al.
Publicado: (2023)

WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY
por: Cheema, S., et al.
Publicado: (2023)

WCN23-0886 CONTRIBUTION TO THE STUDY OF ADVERSE EVENTS FOLLOWING VACCINATION AGAINST COVID-19 IN CHRONIC HEMODIALYSIS PATIENTS IN SENEGAL: A REVIEW OF 367 CASES
por: SARR, I., et al.
Publicado: (2023)

WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
por: Stepanova MD, N., et al.
Publicado: (2023)

WCN23-0544 CLINICAL PROFILE, IMMUNOSUPPRESSIVE MANAGMENT AND OUTCOME IN ADULT RENAL ALLOGRAFT RECIPIENTS WITH COVID-19 INFECTION: A CASE SERIES FROM SINGLE CENTRE IN BANGLADESH
por: MAHJABIN, S., et al.
Publicado: (2023)

WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
por: KLOCHKOVA, N., et al.
Publicado: (2023)

WCN23-1019 CUMULATIVE INCIDENCE OF COVID-19 AND VACCINE PROFILES AMONG ASEAN PERITONEAL DIALYSIS POPULATIONS: A PRELIMINARY RESULT OF THE "InCoV-PD" STUDY GROUP
por: Mushahar, L., et al.
Publicado: (2023)

WCN23-0291 USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN-RECEPTOR BLOCKERS (ARBs) AND INCIDENCE OF PNEUMONIA OR INFLUENZA OR COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Qin, X., et al.
Publicado: (2023)

WCN23-1093 First report of durability of antibody response in maintenance haemodialysis patients and kidney transplant recipients vaccinated with ChAdOx1 nCoV-19 vaccine: A prospective, multicentre, observational, study
por: CHAUHAN, S.
Publicado: (2023)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

Renal artery intervention utilizing carbon dioxide angiography
por: Sag, Alan A, et al.
Publicado: (2017)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Current trends in European renal epidemiology
por: Heaf, James
Publicado: (2017)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Quality of life with conservative care compared with assisted peritoneal dialysis and haemodialysis
por: Iyasere, Osasuyi, et al.
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Impact of a phone app on nephrology referral
por: Oliva-Damaso, Nestor, et al.
Publicado: (2018)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Anticoagulant-related nephropathy: systematic review and meta-analysis
por: de Aquino Moura, Karolinny Borinelli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6h979ocf82ono7euiq3cvf3dro